Location:Room Paris (Hall B2, level 0)
Factors from tumour microenvironment are recognised as regulators of cancer progression. In this session, novel chemokines and miRNA which have a key role in bladder carcinogenesis will be discussed.
- Poster viewing of 20 minutes. Presentations will take place on stage. Standard presentations are 2 minutes in length, followed by 2 minutes for discussion.
Institutes: 1Baylor College of Medicine, Dept. of Urology, Houston, United States of America, 2BC Cancer Agency, Genome Sciences Center, Vancouver, Canada, 3University of Houston, Dept. of Biology & Biochemistry, Houston, United States of America, 4University of North Carolina, Dept. of Genetics, Chapel Hill, United States of America, 5Harvard, Broad Institute, Boston, United States of America, 6Memorial Sloan Kettering Cancer Center, Dept. of Medical Oncology, New York, United States of America, 7MD Anderson Cancer Center, Computational Biology, Houston, United States of America
Institutes: 1Oyokyo Kidney Research Institute, Dept. of Cancer Immunology and Cell Biology, Hirosaki, Japan, 2Graduate School of Medicine, Hirosaki University, Dept. of Urology, Hirosaki, Japan, 3Akita University, Dept. of Urology, Akita, Japan, 4Graduate School of Health Sciences, Hirosaki University, Dept. of Biomedical Sciences, Hirosaki, Japan, 5Vienna University, Dept. of Biochemistry and Cell Biology, Vienna, Austria
Institutes: 1University of the Basque Country, Dept. of Translational Oncology Laboratory, Vitoria-Gasteiz, Spain, 2Fundacion Jimenez Diaz, Dept. of Nephrology, Madrid, Spain, 3Spanish National Cancer Research Center, Dept. of Genomics, Vitoria-Gasteiz, Spain, 4Hospital La Paz, Dept. of Pathology, Madrid, Spain